Agnostic and thorough consultation makes way for successful implementation of business-critical SAP BusinessObjects version upgrade LAS VEGAS–(BUSINESS WIRE)–#riministreet—Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, today announced that Clifford Hallam Healthcare (CH2), Australia’s only … [Read more…]

Leader in organ transplant technologies secures institutional growth capital to drive organ preservation innovation and commercial expansion CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare Partners. This growth investment will bolster Paragonix Technologies’ commercial footprint, including its … [Read more…]

Study from the Tisch MS Research Center of New York suggests that microglia could be a potential target for mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy NEW YORK–(BUSINESS WIRE)–The Tisch MS Research Center of New York (MSRCNY), the world’s largest independent research center focused on multiple sclerosis, has published new research finding that microglia … [Read more…]

WESTBOROUGH, Mass.–(BUSINESS WIRE)–#ACLrestoration—Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced it has entered into a distribution agreement with Veteran’s Health Medical Supply (VHMS). The agreement provides customers in 236 Department of Defense (DOD) and Department of … [Read more…]

SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2022, on Monday, March 13, 2023, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific … [Read more…]

The research, commissioned by Perfect Day and Cargill, finds 2 in 3 Americans believe we need food that uses fewer resources like energy, water, or carbon BELLEVUE, Wash.–(BUSINESS WIRE)–The Hartman Group, a leader in food and beverage research and consulting, in partnership with precision fermentation leaders Perfect Day and Cargill, has released a new white … [Read more…]

– Led by Sectoral Asset Management, with participation from new investors Alpha Wave Ventures and Point 72 Asset Management, and existing investors RA Capital, Versant Ventures, RTW Investments and others – Proceeds enable LENZ to complete the development and registration and, pending approval, launch LNZ100/101 in the United States – Pivotal phase 3 CLARITY trial … [Read more…]

IRVINE, Calif. & PHILADELPHIA–(BUSINESS WIRE)–Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration. With an emphasis on advancing the forefront remote patient monitoring and telehealth, as well as automating high-quality care, the … [Read more…]

– Sunovion’s patient support program is recognized four years in a row by J.D. Power for providing an outstanding customer service experience – MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the Company’s patient support program, Sunovion Answers, has been named as a J.D. Power 2022 Certified Customer Service Program℠. Sunovion Answers has been … [Read more…]

Arcturus to present at the Guggenheim Healthcare Talks: Genomic Medicines & Rare Disease Day, April 3, 2023 SAN DIEGO–(BUSINESS WIRE)–Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced … [Read more…]